UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical characteristics and quality‐of‐life in patients surviving a decade of prostate cancer with bone metastases

BJU international, 2016-06, Vol.117 (6), p.904-913

2016

Volltextzugriff (PDF)

Predictors of early androgen deprivation treatment failure in prostate cancer with bone metastases

Cancer medicine (Malden, MA), 2016-03, Vol.5 (3), p.407-414

2016

Volltextzugriff (PDF)

Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality

Urology (Ridgewood, N.J.), 2000-03, Vol.55 (3), p.328-332

2000

Volltextzugriff (PDF)

PSA Kinetics Provide Improved Prediction of Survival in Metastatic Hormone-Refractory Prostate Cancer

Urology (Ridgewood, N.J.), 2008-10, Vol.72 (4), p.903-907

2008

Volltextzugriff (PDF)

Deferred treatment of clinically localized low-grade prostate cancer: Actual 10-year and projected 15-year follow-up of the karolinska series

Urology (Ridgewood, N.J.), 1997-11, Vol.50 (5), p.722-726

1997

Volltextzugriff (PDF)

Clinical and prognostic significance of changes in haemoglobin concentration during 1year of androgen-deprivation therapy for hormone-naïve bone-metastatic prostate cancer

BJU international, 2018, Vol.122 (4), p.583

2018

Volltextzugriff (PDF)

Clinical presentation and predictors of survival related to extent of bone metastasis in 900 prostate cancer patients

Scandinavian journal of urology, 2016-10, Vol.50 (5), p.352-359

2016

Volltextzugriff (PDF)

Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial

Scandinavian journal of urology and nephrology, 2011-11, Vol.45 (5), p.346-353

2011

Volltextzugriff (PDF)

Side effects of endocrine treatment and their mechanisms: Castration, antiandrogens, and estrogens

The Prostate, 2000, Vol.45 (S10), p.32-37

Hedlund, Per Olov

2000

Volltextzugriff (PDF)

DEFERRED TREATMENT OF LOCALLY ADVANCED NONMETASTATIC PROSTATE CANCER: A LONG-TERM FOLLOWUP

The Journal of urology, 1999-02, Vol.161 (2), p.505-508

1999

Volltextzugriff (PDF)

DEFERRED TREATMENT OF LOCALLY ADVANCED NONMETASTATIC PROSTATE CANCER: A LONG-TERM FOLLOWUP

The Journal of urology, 1999-02, p.505-508

1999

Volltextzugriff (PDF)

The Scandinavian Prostatic Cancer Group: A Short Review of its History and Work

Scandinavian journal of urology and nephrology, 1999, Vol.33 (203), p.53-56

Hedlund, Per Olov

1999

Volltextzugriff (PDF)

Deferred Treatment of Clinically Localized Low Grade Prostate Cancer: The Experience From A Prospective Series at The Karolinska Hospital

The Journal of urology, 1994-11, Vol.152 (5), p.1757-1760

1994

Volltextzugriff (PDF)

Endocrine treatment: Expected duration stage by stage

The Prostate, 2000, Vol.45 (S10), p.26-31

Schr der, Fritz H.

2000

Volltextzugriff (PDF)

The Prognostic Value of Modal Deoxyribonucleic Acid in Low Grade, Low Stage Untreated Prostate Cancer

The Journal of urology, 1990-12, Vol.144 (6), p.1404-1406

1990

Volltextzugriff (PDF)

Clinical research done by the Scandinavian Prostate Cancer Group during the first 20 years

Scandinavian journal of urology and nephrology, 2003, Vol.37 (212), p.7-10

2003

Volltextzugriff (PDF)

The Scandinavian Prostatic Cancer Group. A short review of its history and work

Scandinavian journal of urology and nephrology, 1999-01, Vol.203 (6), p.53-56

Hedlund, P O

1999

Volltextzugriff (PDF)

Evaluation and follow-up of patients with n1-3 m0 or nxm1 prostate cancer in phase iii trials

Urology (Ridgewood, N.J.), 1997-04, Vol.49 (4), p.39-45

1997

Volltextzugriff (PDF)

Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5

Scandinavian journal of urology and nephrology, 2008, Vol.42 (3), p.220-229

2008

Volltextzugriff (PDF)

Squamous metaplasia in hormonallytreated prostatic cancer significance during follow-up

Urology (Ridgewood, N.J.), 1991, Vol.38 (1), p.70-75

1991

Volltextzugriff (PDF)

Changes in blood coagulation and fibrinolysis in patients on different treatment regimens for prostatic cancer. - predictors for cardiovascular complications?

Thrombosis research, 1988, Vol.49 (1), p.111-121

1988

Volltextzugriff (PDF)

Determination of false negative rate in fine-needle aspiration of prostate

Urology (Ridgewood, N.J.), 1989-08, Vol.34 (2), p.73-75

1989

Volltextzugriff (PDF)

Rectal palpation and transrectal fine needle aspiration of the prostate in the monitoring of prostate cancer: A study of 59 patients during treatment with estramustine phosphate or estrogens

The Prostate, 1989, Vol.15 (4), p.327-333

1989

Volltextzugriff (PDF)

Quality of life in patients with skeletal metastases of prostate cancer and status prior to start of endocrine therapy: Results from the scandinavian prostate cancer group study 5

Scandinavian journal of urology and nephrology, 2005-01, Vol.39 (1), p.42-48

2005

Volltextzugriff (PDF)

Improved early detection of recurrence in prostatic carcinoma following hormonal therapy combined use of palpation and fine needle aspiration cytology

Urology (Ridgewood, N.J.), 1990-10, Vol.36 (4), p.341-345

1990

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical characteristics and quality‐of‐life in patients surviving a decade of prostate cancer with bone metastases

Predictors of early androgen deprivation treatment failure in prostate cancer with bone metastases

Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality

PSA Kinetics Provide Improved Prediction of Survival in Metastatic Hormone-Refractory Prostate Cancer

Deferred treatment of clinically localized low-grade prostate cancer: Actual 10-year and projected 15-year follow-up of the karolinska series

Clinical and prognostic significance of changes in haemoglobin concentration during 1year of androgen-deprivation therapy for hormone-naïve bone-metastatic prostate cancer

Clinical presentation and predictors of survival related to extent of bone metastasis in 900 prostate cancer patients

Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial

Side effects of endocrine treatment and their mechanisms: Castration, antiandrogens, and estrogens

DEFERRED TREATMENT OF LOCALLY ADVANCED NONMETASTATIC PROSTATE CANCER: A LONG-TERM FOLLOWUP

DEFERRED TREATMENT OF LOCALLY ADVANCED NONMETASTATIC PROSTATE CANCER: A LONG-TERM FOLLOWUP

The Scandinavian Prostatic Cancer Group: A Short Review of its History and Work

Deferred Treatment of Clinically Localized Low Grade Prostate Cancer: The Experience From A Prospective Series at The Karolinska Hospital

Endocrine treatment: Expected duration stage by stage

The Prognostic Value of Modal Deoxyribonucleic Acid in Low Grade, Low Stage Untreated Prostate Cancer

Clinical research done by the Scandinavian Prostate Cancer Group during the first 20 years

The Scandinavian Prostatic Cancer Group. A short review of its history and work

Evaluation and follow-up of patients with n1-3 m0 or nxm1 prostate cancer in phase iii trials

Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5

Squamous metaplasia in hormonallytreated prostatic cancer significance during follow-up

Changes in blood coagulation and fibrinolysis in patients on different treatment regimens for prostatic cancer. - predictors for cardiovascular complications?

Determination of false negative rate in fine-needle aspiration of prostate

Rectal palpation and transrectal fine needle aspiration of the prostate in the monitoring of prostate cancer: A study of 59 patients during treatment with estramustine phosphate or estrogens

Quality of life in patients with skeletal metastases of prostate cancer and status prior to start of endocrine therapy: Results from the scandinavian prostate cancer group study 5

Improved early detection of recurrence in prostatic carcinoma following hormonal therapy combined use of palpation and fine needle aspiration cytology

Suchergebnisse filtern